Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion

Enzo Emanuele1, Colomba Falcone, Maria Carabela

  • 1Molecular Medicine Laboratory, IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy.

Insights

Genetic analysis of Kir6.1/KCNJ8 in Italian patients revealed no mutations, suggesting this gene is not a common cause of abnormal coronary vasomotion in this population. Further research across diverse ethnic groups is needed.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Channelopathies

Background:

  • Abnormal coronary vasomotor tone is a clinical concern, with potential links to vascular smooth muscle cell defects.
  • Mouse models involving Kir6.1/Kcnj8 and Sur2 disruptions exhibit phenotypes resembling human variant angina.
  • ATP-sensitive potassium channels (KATP) in smooth muscle are implicated in coronary vasomotion regulation.

Purpose of the Study:

  • To investigate the role of smooth muscle KATP channels in abnormal coronary vasomotion.
  • To perform a comprehensive mutational analysis of the Kir6.1/KCNJ8 gene in Italian patients with impaired coronary vasomotility.

Main Methods:

  • Mutational analysis of the Kir6.1/KCNJ8 gene.
  • Polymerase chain reaction (PCR) amplification of gene segments.
  • Direct sequencing of PCR products from 18 Italian patients.

Main Results:

  • No mutations in the Kir6.1/KCNJ8 gene were detected in the analyzed cohort of Italian patients.
  • This finding suggests Kir6.1/KCNJ8 gene alterations are not a frequent cause of abnormal coronary vasomotion in this specific ethnic group.
  • This study represents the first human mutational analysis of the Kir6.1/KCNJ8 gene.

Conclusions:

  • Kir6.1/KCNJ8 gene mutations are unlikely to be a common cause of impaired coronary vasomotility in the Italian population.
  • Further studies are necessary to explore the role of Kir6.1/KCNJ8 in other ethnic groups due to reported racial differences in vasospastic angina prevalence.
  • The precise molecular mechanisms of abnormal coronary vasomotion require continued investigation.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...